Abstract:The presence of somatic beta-catenin mutations in some prostate cancers implies that aberrant WNT signaling is involved in the cancer development. Although beta-catenin stability is regulated by a multicomponent destruction complex, mutational alterations of beta-catenin or other components of the destruction complexes are rare in prostate tumors. Therefore, beta-catenin may be regulated by another protein in the prostate. In fact, recent linkage and somatic deletion analyses in prostate cancers reveal a 1.4-Mb candidate tumor suppressor locus on 8p23.1, which includes the Sox7 gene. Here we show that Sox7 protein expression was indeed down-regulated in 47% (15 of 32) of prostate adenocarcinomas. In addition, Sox7 mRNA was down-regulated in 60% of snap-frozen tumors. This down-regulation was found to be due to tumor-specific promoter hypermethylation, which was present in 48% (10 of 21) of primary prostate tumors and 44% (11 of 25) of prostate cancer cell lines/xenografts. We discovered that Sox7 protein physically interacts with beta-catenin and suppresses beta-catenin-mediated transcription by depleting active beta-catenin. Furthermore, in HCT116 colorectal cancer cell lines with Sox7 inactivation, ectopic Sox7 expression suppressed cell proliferation and inhibited transcription that was activated by an endogenous mutant beta-catenin. Although nearly all colorectal cancers contain mutations in beta-catenin or adenomatous polyposis coli/axin, epigenetic silencing of Sox7 was still observed. These data suggest that Sox7 is a tumor suppressor that functions as an independent checkpoint for beta-catenin transcriptional activity. Inactivation of Sox7 could promote the development of a majority of colorectal tumors and approximately half of prostate tumors.

SOX10, a Novel HMG-box-containing Tumor Suppressor, Inhibits Growth and Metastasis of Digestive Cancers by Suppressing the Wnt/β-catenin Pathway.

Analysis of SOX9 Expression in Colorectal Cancer.

Homeobox D10 Gene, a Candidate Tumor Suppressor, is Downregulated Through Promoter Hypermethylation and Associated with Gastric Carcinogenesis

Silencing Sox2 Induced Mesenchymal-Epithelial Transition And Its Expression Predicts Liver And Lymph Node Metastasis Of Crc Patients

SOX6 represses tumor growth of clear cell renal cell carcinoma by HMG domain-dependent regulation of Wnt/β-catenin signaling.

SOX17 Antagonizes WNT/β-catenin Signaling Pathway in Hepatocellular Carcinoma

SOX30 Inhibits Tumor Metastasis Through Attenuating Wnt-Signaling Via Transcriptional and Posttranslational Regulation of Β-Catenin in Lung Cancer

SOX1 Inhibits Breast Cancer Cell Growth and Invasion Through Suppressing the Wnt/β-catenin Signaling Pathway.

SOX15 Exerts Antitumor Function in Glioma by Inhibiting Cell Proliferation and Invasion Via Downregulation of Wnt/β-catenin Signaling.

Data from Characterization of Tumor-Suppressive Function of <i>sox6</i> in Human Esophageal Squamous Cell Carcinoma

SOX2, a Predictor of Survival in Gastric Cancer, Inhibits Cell Proliferation and Metastasis by Regulating PTEN

Sox7 Is an independent checkpoint for beta-catenin function in prostate and colon epithelial cells

Sox15 Methylation Inhibits Cell Proliferation Through Wnt Signaling in Hepatocellular Carcinoma

SOX2 Promotes Tumor Metastasis by Stimulating Epithelial-to-mesenchymal Transition Via Regulation of WNT/β-catenin Signal Network.

SOX12 Promotes the Growth of Multiple Myeloma Cells by Enhancing Wnt/β-catenin Signaling.

SOX17 restrains proliferation and tumor formation by down-regulating activity of the Wnt/β-catenin signaling pathway via trans-suppressing β-catenin in cervical cancer

Abstract LB-90: Sox17 Antagonizes Wnt/ß-catenin Signaling Pathway in HCC

Effects of SOX15 on the colorectal cancer cells via downregulation of the Wnt/β-catenin signaling pathway.

The Molecular Mechanism Governing the Oncogenic Potential of SOX2 in Breast Cancer.

Advance in the Research of the Roles of SOX4 in Tumorigenesis

Intervention of epithelial mesenchymal transition against colon cancer cell growth and metastasis based on SOX21/POU4F2/Hedgehog signaling axis